Loading...
Spotlight on eltrombopag in the treatment of children with chronic immune thrombocytopenia
Pediatric data on the use of thrombopoietin receptor agonists are fairly limited. The recent approval of eltrombopag by the US Food and Drug Administration for children aged ≥1 year, based on data from two randomized, placebo-controlled clinical trials, may lead to the increased use of this drug in...
Na minha lista:
| Udgivet i: | Pediatric Health Med Ther |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5683296/ https://ncbi.nlm.nih.gov/pubmed/29388634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PHMT.S90688 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|